Research Article

Improving Long-Term Outcomes for Patients with Extra-Abdominal Soft Tissue Sarcoma Regionalization to High-Volume Centers, Improved Compliance with Guidelines or Both?

Table 5

Multivariable analysis for margin negative surgery.

VariableComparisonaOR95% CI value

Volume2nd versus 1st tercile1.261.081.470.003
3rd versus 1st tercile1.771.512.08<0.001
AgePer 1-year older0.980.980.99<0.001
SiteHead/neck versus extremity0.670.500.890.005
Overlapping versus extremity0.680.490.950.03
Trunk versus extremity0.920.801.060.25
Tumor size5–10 cm versus < 5 cm0.550.470.66<0.001
>10 cm versus < 5 cm0.370.320.45<0.001
GradeModerately differentiated versus well differentiated1.110.881.400.37
Poorly differentiated versus well differentiated1.020.841.230.86
Undifferentiated versus well differentiated0.980.791.210.85
Cell type not determined versus well differentiated1.130.901.410.30
HistologyLeiomyosarcoma versus fibrosarcoma1.431.051.940.02
Liposarcoma versus fibrosarcoma0.890.671.190.45
MFH versus fibrosarcoma1.280.951.720.11
MPNST versus fibrosarcoma0.640.440.930.02
Myxofibroma versus fibrosarcoma0.590.271.270.18
NOS versus fibrosarcoma1.070.811.410.65

Amputation cases excluded (); MFH, malignant fibrous histiocytoma; MPNST, malignant peripheral nerve sheath tumor; NOS, not otherwise specified.